pharma · Urinary Tract Infections · Respiratory Tract Infection Viral · ITRMF
Iterum Therapeutics
Iterum Therapeutics plc
Iterum Therapeutics is a pharma organization headquartered in Dublin, IE. It trades on NYSE under ticker ITRMF. Primary therapeutic focus areas include Urinary Tract Infections, Respiratory Tract Infection Viral, UTI - L
Dublin, IE HQ
2015 Founded
19 Employees
Public company Type
ITRMF · NYSE Ticker
Company details
- Status
- Public
- HQ
- Dublin, IE
- Founded
- 2015
- Employees
- 19
- Programs
- 8
- Drugs
- 8
- Patents
- 3
Sulopenem-Etzadroxil/Probenecid
Phase 3 · small molecule · Uncomplicated Urinary Tract Infections
Sulopenem-Etzadroxil/Probenecid for Uncomplicated Urinary Tract Infections is a Phase 3 program (small_molecule) at Iterum Therapeutics plc with 1 ClinicalTrials.gov record(s).
Internal code IT001-301
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Iterum Therapeutics plc
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Uncomplicated Urinary Tract Infections
- Status
- completed
- Trials
- 1